Skip to main content
Figure 2 | BMC Cancer

Figure 2

From: Selective Internal Radiation Therapy (SIRT) with yttrium-90 resin microspheres plus standard systemic chemotherapy regimen of FOLFOX versus FOLFOX alone as first-line treatment of non-resectable liver metastases from colorectal cancer: the SIRFLOX study

Figure 2

Treatment received as part of the SIRFLOX study. Figure footnote: Bevacizumab can be added at the investigator’s discretion starting at cycle 1 (or according to the institutional protocol). Bevacizumab can be added at the investigator’s discretion but should not be initiated until cycle 4 (or according to the institutional protocol). If leucovorin is not available, levofolinic acid can be used at a dose of 100 mg/m2. If a centre considers leucovorin 400 mg/m2 the standard dose, then this will be allowed at the investigator’s discretion. LV = Leucovorin; 5-FU =5-Fluorouracil.

Back to article page